In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

Autor: Aspeslagh, Sandrine, Matias, Margarida, Palomar, Virginia, Dercle, Laurent, Lanoy, Emilie, Soria, Jean-Charles, Postel-Vinay, Sophie
Zdroj: In European Journal of Cancer December 2017 87:65-74
Databáze: ScienceDirect